European Companies Search Engine
State Aid (€500,000 - €1,000,000): Extension and amendment of scheme N866 / 2006 - Tax exemptions for certain renewable energy sources used for heat generation Sat31 Dec 2019 State Aid Transparency (Tax advantage or tax exemption)
Overview
Text
| Country | Sweden |
| Language | Swedish |
| Aid Measure Title | Extension and amendment of scheme N866 / 2006 - Tax exemptions for certain renewable energy sources used for heat generation (en: Extension and amendment of scheme N866/2006 — Tax exemptions for certain renewable energy sources used for heat generation) |
| SA.Number | SA.49893 |
| Ref-no. | TM-10238699 |
| National ID | 556011-7482 |
| Beneficiary National ID Type | Organisationsnummer |
| Name of the beneficiary | AstraZeneca AB |
| Beneficiary Type | Only large enterprises |
| Region | Västsverige |
| Sector (NACE) | Manufacture of pharmaceutical preparations |
| Aid Instrument | Tax advantage or tax exemption |
| Objectives of the Aid | Environmental protection |
| Date of Granting | 31/12/2019 |
| Aid element, expressed as full amount | 500,000 - 1,000,000 EUR |
| Granting Authority Name | Skatteverket (en: Swedish Tax Agency) |
| Co-finance | ✗ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: AstraZeneca AB, Södertälje, Sweden.
The visualizations for "AstraZeneca AB - State Aid (€500,000 - €1,000,000): Extension and amendment of scheme N866 / 2006 - Tax exemptions for certain renewable energy sources used for heat generation"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
